Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/09/23 12:50:17」(JST)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 小児における歯周病：関連する全身疾患 periodontal disease in children associated systemic conditions
2. 骨軟化症の臨床症状、診断、および治療 clinical manifestations diagnosis and treatment of osteomalacia
3. 髄膜炎菌の微生物学および病理生物学 microbiology and pathobiology of neisseria meningitidis

Cyclen-based cationic lipids containing a pH-sensitive moiety as gene delivery vectors.

Huang Z1, Liu YH, Zhang YM, Zhang J, Liu Q, Yu XQ.
Organic & biomolecular chemistry.Org Biomol Chem.2015 Jan 14;13(2):620-30. doi: 10.1039/c4ob01856g. Epub 2014 Nov 5.
A series of novel cationic lipids based on 1,4,7,10-tetrazacyclododecane (cyclen) with the imidazole group as the pH-sensitive moiety and various aliphatic long chains were designed and synthesized. Cationic liposomes were prepared by mixing the lipids and the helper lipid 1,2-dioleoyl-sn-glycero-3-
PMID 25372457

Stalk formation as a function of lipid composition studied by X-ray reflectivity.

Khattari Z1, Köhler S2, Xu Y2, Aeffner S2, Salditt T3.
Biochimica et biophysica acta.Biochim Biophys Acta.2015 Jan;1848(1 Pt A):41-50. doi: 10.1016/j.bbamem.2014.08.010. Epub 2014 Sep 28.
We have investigated the structure and interaction of solid-supported multilamellar phospholipid bilayers in view of stalk formation as model systems for membrane fusion. The multi-component bilayers were composed of ternary and quaternary mixtures, containing phosphatidylcholines, phosphatidylethan
PMID 25261611

How polyunsaturated fatty acids modify molecular organization in membranes: Insight from NMR studies of model systems.

Shaikh SR1, Kinnun JJ2, Leng X2, Williams JA2, Wassall SR3.
Biochimica et biophysica acta.Biochim Biophys Acta.2015 Jan;1848(1PB):211-219. doi: 10.1016/j.bbamem.2014.04.020. Epub 2014 May 9.
Marine long chain n-3 polyunsaturated fatty acids (PUFA), eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), are bioactive molecules with clinical applications for the treatment of several diseases. In order to effectively translate these molecules into clinical trials, it is essential to establ
PMID 24820775

siRNA Delivery into Tumor Cells by Cationic Cholesterol Derivative-Based Nanoparticles and Liposomes

, , [他], , , , , , ,
Biological and Pharmaceutical Bulletin 38(1), 30-38, 2015
… diamine-type cationic cholesteryl carbamate (OH-C-Chol, cholesteryl (2-((2-hydroxyethyl)amino)ethyl)carbamate) and triamine-type carbamate (OH-NC-Chol, cholesteryl (2-((2-((2-hydroxyethyl)amino)ethyl)amino)ethyl)carbamate), and prepared cationic nanoparticles composed of OH-C-Chol or OH-NC-Chol with Tween 80 (NP-C and NP-NC, respectively), as well as cationic liposomes composed of OH-C-Chol or OH-NC-Chol with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) (LP-C and LP-NC, respectively) for evaluation of their possible use as siRNA delivery …
NAID 130004872237

An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells

Ara Mst Naznin,Matsuda Takashi,Hyodo Mamoru,Sakurai Yu,Hatakeyama Hiroto,Ohga Noritaka,Hida Kyoko,Harashima Hideyoshi
Biomaterials 35(25), 7110-7120, 2014-08
… We first synthesized an aptamer-polyethylene glycol 2000-distearoyl phosphoethanolamine (Apt-PEG(2000)-DSPE). …
NAID 120005512022

Purification, characterization, molecular cloning, and extracellular production of a novel bacterial glycerophosphocholine cholinephosphodiesterase from Streptomyces sanglieri(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)

Sugimori Daisuke,Ogasawara Junki,Okuda Koki,Murayama Kazutaka
Journal of bioscience and bioengineering 117(4), 422-430, 2014-04
… The enzyme exhibited specificity toward GPC and glycerol-3-phosphoethanolamine and hydrolyzed glycerol-3-phosphate and lysophosphatidylcholine. …
NAID 110009817056

リンク元	「ホスホエタノールアミン」
拡張検索	「alkylglycerophosphoethanolamines」

Phosphorylethanolamine
Identifiers
CAS number	1071-23-4
PubChem	1015
ChemSpider	990
DrugBank	DB04403
MeSH	phosphorylethanolamine
ChEBI	CHEBI:17553
ChEMBL	CHEMBL146972
	InChI InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6) ; Key: SUHOOTKUPISOBE-UHFFFAOYSA-N ;
Properties
Molecular formula	C2H8NO4P
Molar mass	141.063 g/mol
Appearance	white powder
	(verify) (what is: /?); Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
	Infobox references

Phosphorylethanolamine

Identifiers
CAS number	1071-23-4^Y
PubChem	1015
ChemSpider	990^Y
DrugBank	DB04403
MeSH	phosphorylethanolamine
ChEBI	CHEBI:17553^Y
ChEMBL	CHEMBL146972^Y
InChI InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)^Y Key: SUHOOTKUPISOBE-UHFFFAOYSA-N^Y
Properties
Molecular formula	C₂H₈NO₄P
Molar mass	141.063 g/mol
Appearance	white powder
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references